Molecular characterization of breast cancer CTCs associated with brain metastasis
Characterization of CTCs derived from breast cancer patients with brain metastasis (BCBM) may allow for early diagnosis of brain metastasis and/or help for treatment choice and its efficacy. In this study, the authors identify a unique signature, based on patient-derived CTCs transcriptomes, for BCB...
Guardado en:
Autores principales: | Debasish Boral, Monika Vishnoi, Haowen N. Liu, Wei Yin, Marc L. Sprouse, Antonio Scamardo, David S. Hong, Tuan Z. Tan, Jean P. Thiery, Jenny C. Chang, Dario Marchetti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/924c0ac03d9d404c931127a48b58fb79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice
por: Bashar Hamza, et al.
Publicado: (2021) -
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Zdeněk Kejík, et al.
Publicado: (2021) -
Molecular mediators of breast cancer metastasis
por: Ragini Yeeravalli, et al.
Publicado: (2021) -
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
por: Yun-Fan Sun, et al.
Publicado: (2021) -
Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
por: Silvia González-Martínez, et al.
Publicado: (2021)